TrialPloS one2017

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.

Joshua A Beckman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.